SynthesisMedicine2017

Combination therapy of metformin plus dipeptidyl peptidase-4 inhibitor versus metformin plus sulfonylurea and their association with a decreased risk of cardiovascular disease in type 2 diabetes mellitus patients.

Fei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.